Essmedi - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 10,797,402 | 11,842,374 | 37,360,604 | 21,343,779 | 22,393,429 | 28,223,837 | 25,258,674 | 24,130,254 |
| Profit before tax | 315,324 | 414,851 | 5,543,316 | 762,808 | 907,844 | 539,292 | 242,349 | 309,910 |
| Net profit | 266,686 | 340,786 | 5,016,813 | 678,228 | 789,959 | 477,934 | 168,663 | 245,054 |
| Equity | 865,169 | 1,126,954 | 4,285,169 | 4,463,397 | 4,653,356 | 4,931,289 | 4,861,952 | 4,377,006 |
| Liabilities | 1,156,832 | 1,565,144 | 2,067,642 | 3,178,912 | 2,981,570 | 4,697,530 | 4,746,222 | 5,020,562 |
| Non-current assets | 144,048 | 277,456 | 1,008,471 | 1,894,837 | 1,932,087 | 1,865,140 | 2,005,787 | 2,031,202 |
| Current assets | 1,868,634 | 2,410,475 | 5,336,890 | 6,048,384 | 5,699,747 | 7,702,283 | 7,541,965 | 7,350,607 |
| Total assets | 2,012,682 | 2,687,931 | 6,345,361 | 7,943,221 | 7,631,834 | 9,567,423 | 9,547,752 | 9,381,809 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | - | 15,013 | 104,273 |
| Social insurance contributions | - | - | - | - | - | 191,350 | 200,194 | 198,393 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +4.1% | +9.7% | +215.5% | -42.9% | +4.9% | +26.0% | -10.5% | -4.5% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 13.3% | 12.7% | 79.1% | 8.5% | 10.4% | 5.0% | 1.8% | 2.6% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 30.8% | 30.2% | 117.1% | 15.2% | 17.0% | 9.7% | 3.5% | 5.6% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 2.5% | 2.9% | 13.4% | 3.2% | 3.5% | 1.7% | 0.7% | 1.0% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 2.9% | 3.5% | 14.8% | 3.6% | 4.1% | 1.9% | 1.0% | 1.3% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 1.3 | 1.4 | 0.5 | 0.7 | 0.6 | 1.0 | 1.0 | 1.1 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 578,431 | 676,707 | 2,252,905 | 1,243,325 | 1,492,895 | 1,338,682 | 1,122,608 | 1,068,500 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Essmedi - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2025-12-16 | 2025-12-16 | 11808.13 |
| 2025-03-21 | 2025-03-25 | 25.06 |
| 2024-12-22 | 2024-12-26 | 8436.03 |
| 2024-12-17 | 2024-12-20 | 8436.03 |
Essmedi - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-07-12 | 2025-07-20 | 866.92 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Essmedi, UAB (code 302615244) is a Private Limited Liability Company engaged in the wholesale of pharmaceutical and medical goods. In 2025, the company generated revenue of €24.13M, down 4.5% year on year and 14.5% below the 2023 level. Net profit for 2025 was €245.1K, up from €168.7K in 2024 but still below the €477.9K reported in 2023. The profit margin improved to 1.0% in 2025 after 0.7% in 2024 and 1.7% in 2023, indicating a modest recovery in profitability despite lower sales. Balance sheet totals remained broadly stable, with total assets of €9.38M, equity of €4.38M and liabilities of €5.02M at the end of 2025. The equity ratio stood at 46.6%, debt-to-equity at 1.15, asset turnover at 2.57x, ROE at 5.6% and ROA at 2.6%. The company reported revenue per employee of €1.10M and profit per employee of €11.1K, showing strong sales productivity.